Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

37.90USD
2 Dec 2016
Change (% chg)

$0.30 (+0.80%)
Prev Close
$37.60
Open
$37.72
Day's High
$38.07
Day's Low
$37.60
Volume
1,687,203
Avg. Vol
2,432,164
52-wk High
$46.21
52-wk Low
$36.00

ABT.N

Chart for ABT.N

About

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $58,539.03
Shares Outstanding(Mil.): 1,472.31
Dividend: 0.26
Yield (%): 2.62

Financials

  ABT.N Industry Sector
P/E (TTM): 59.80 29.13 29.87
EPS (TTM): 0.66 -- --
ROI: 3.11 15.56 14.95
ROE: 4.74 16.69 16.29

EU regulator conditionally approves Abbott's purchase of St Jude

BRUSSELS The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc .

Nov 23 2016

EU regulator conditionally approves Abbott's purchase of St Jude

BRUSSELS, Nov 23 The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc.

Nov 23 2016

Fitch Rates Abbott's Notes Offering 'A(EXP)'; Rating Watch Negative

(The following statement was released by the rating agency) CHICAGO, November 18 (Fitch) Fitch Ratings has assigned an 'A(EXP)' rating with a Negative Rating Watch to Abbott Laboratories' (ABT, Abbott) notes offering. The net proceeds are expected to be used to fund the company's acquisition of St. Jude Medical Inc. (STJ, St. Jude). Abbott is also in the process of potentially acquiring Alere Inc. (Alere). Fitch will resolve the Rating Watch as more details regarding the transaction become

Nov 18 2016

Exclusive: EU regulators seen clearing $25 billion Abbott, St Jude deal: source

EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories' $25 billion bid for rival St. Jude Medical Inc , a person familiar with the matter said on Tuesday.

Nov 15 2016

Deals of the day - Mergers and acquisitions

Nov 15 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

Nov 15 2016

EU mergers and takeovers (Nov 14)

BRUSSELS, Nov 14 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Nov 14 2016

BRIEF-Abbott says Japan approves its absorbable heart stent

* Abbott laboratories - japan has approved company's absorb bioresorbable heart stent Source text for Eikon: Further company coverage:

Nov 07 2016

2nd Circuit upholds injunction barring sales of glucose test strips

The 2nd U.S. Circuit Court of Appeals has rejected two drug wholesalers' appeal of an injunction barring them from selling in the U.S. blood glucose test strips made by Abbott Laboratories for overseas sale.

Nov 03 2016

EU mergers and takeovers (Nov 3)

BRUSSELS, Nov 3 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Nov 03 2016

Abbott offers EU concessions over $25 billion St. Jude deal

BRUSSELS Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc , according to the European Commision.

Nov 03 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $111.96 +0.58
Pfizer Inc. (PFE.N) $31.63 +0.17
Novartis AG (NOVN.S) CHF68.75 -0.10
Merck & Co., Inc. (MRK.N) $61.13 +0.37
Sanofi SA (SASY.PA) €75.30 +0.14
AstraZeneca plc (AZN.L) 4,055.00p -25.00
GlaxoSmithKline plc (GSK.L) 1,467.00p -1.50
Eli Lilly and Co (LLY.N) $67.71 +1.74
Amgen, Inc. (AMGN.OQ) $144.01 +1.62
Boston Scientific Corporation (BSX.N) $20.35 +0.26

Earnings vs. Estimates